Seppic, a subsidiary of Air Liquide Healthcare, and Botalys, a Belgian start-up specialized in the cultivation of rare and medicinal plants, have signed a research partnership for the co-development of new ingredients for the cosmetics and health markets, as well as distribution contracts in various markets and geographies, for Botalys’ Ginseng-based products.
To meet the growing demand from the cosmetic and pharmaceutical industries for performance and naturalness, Seppic and Botalys are partnering to offer high purity ingredients to cosmetic and healthcare manufacturers.
Botalys, through an innovative process, has developed a technology of vertical farming, to produce ultra pure and efficient botanical ingredients. Botalys supplies ingredients and medicinal plants to a multitude of clients and partners in the cosmetics, dietary supplements and pharmaceutical industries.
Hannes Moeller, CEO of Seppic, states: "We are very pleased with this new partnership with Botalys. This agreement is fully in line with our corporate strategy to develop natural ingredients based on innovative technologies and to distribute exclusive ingredients for the cosmetics and dietary supplements markets, while strengthening our position in the development of new supply chains."
Pierre-Antoine Mariage, CEO of Botalys, says: "This partnership with Seppic thrills the Botalys teams. Our patented and innovative precision farming technology addresses the need for purity, efficacy and security of supply of many rare medicinal plants. This scientific and commercial partnership outlines the huge potential of this technology for the nutraceutical and cosmetic industry."
This partnership follows the announcement on September 29 by ALIAD, the Air Liquide Group's Venture Capital Fund, of its investment in Botalys, in line with its strategy of taking positions in impact start-ups.. It is accompanied by a distribution agreement between Seppic and Botalys. Through its international distribution network, Seppic is particularly well positioned to add significant value to Botalys' business development efforts.
